Immuneering (IMRX) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order at 11:01 A.M. ET on June 11, 2026, with a quorum present and formal agenda outlined.

• Board members, executive officers, and representatives from the independent auditor were introduced.

• Rules of conduct and voting procedures were explained to participants.

Board and executive committee updates

• Election of Peter Feinberg and Laurie B. Keating as Class II directors to serve until the 2029 annual meeting was proposed.

Shareholder proposals

• Two proposals presented: election of directors and ratification of the independent auditor for 2026.

• Board recommended voting in favor of both proposals.